1.7 billion injection varieties This Shanxi pharmaceutical company will be the first to review.

Pharmaceutical Network August 13th, recently, Yabao Pharmaceuticals according to the imitation of 4 categories of reported thioic acid injection registration status changed to "in the approval", is expected to be approved in recent days and the first review.
thioic acid injections are used for diabetes, Minanet data show that in 2019, China's public medical institutions terminal thioic acid injection sales of more than 1.7 billion yuan.
sulphate injection is a diabetic drug used for abnormal sensations caused by neuropathy around diabetes and other diseases caused by oxidative stress.
original drug is Stadt's Otstra, germany has been used in Germany for decades to treat diabetic neuropathy, some domestic manufacturers also used it as a liver protection agent.
meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sulfuric acid injection sales of more than 1.7 billion yuan.
Abao Pharmaceuticals accounted for 35.68 percent of the market share, Chongqing Pharmaceuticals accounted for 23.91 percent, the original research manufacturer Stard accounted for 3.65 percent.
The current domestic market thioic acid injection manufacturers have 15 (14 domestic imports), Yabao Pharmaceuticals this variety has previously been approved for listing.
At present, no enterprises have passed the consistent evaluation of thioic acid injections, and five enterprises, such as Pelt Pharmaceuticals, Huakang Pharmaceuticals, Shenlong Pharmaceuticals, Garden Pharmaceuticals, Dandong Pharmaceuticals, etc., have submitted conformity evaluation supplementary applications in the review;
sulphuric acid injection consistent evaluation of supplementary applications in addition, Yabao Pharmaceuticals, New Era Pharmaceuticals, Tianfang Pharmaceuticals and other 3 enterprises according to the imitation of 4 categories of sulphate injections to submit the listing application, Yabao Pharmaceuticals thioic acid injection registration status has been changed to "in the approval", if successfully approved will become the first evaluation of the variety of enterprises.
sulphate injection imitation of 4 types of reported production sources: Mienet database, NMPA.